Varenicline versus bupropion XL for smoking cessation in older adolescents: A randomized, double-blind pilot trial

Nicotine and Tobacco Research

Volumn 14, Issue 2, 2012, Pages 234-239

  Gray, Kevin M ^a   Carpenter, Matthew J ^a,b   Lewis, A Lee ^a   Klintworth, Erin M ^a   Upadhyaya, Himanshu P ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; FEASIBILITY STUDY; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; INSOMNIA; MALE; NAUSEA; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; THORAX PAIN;

EID: 84856458359     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr130     Document Type: Article

References (42)

1. Aubin, H. J., Bobak, A., Britton, J. R., Oncken, C., Billing, C. B., Jr., Gong, J., et al. (2008). Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomized open-label trial. Thorax, 63, 717-724. doi:10.1136/thx.2007.090647
2. Backinger, C. L., Fagan, P., Matthews, E., & Grana, R. (2003). Adolescent and young adult tobacco prevention and cessation: Current status and future directions. Tobacco Control, 12(Suppl. 4), IV46-IV53. doi:10.1136/tc.12.suppl_4.iv46
3. Beck, T. A., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory manual (2nd ed.). San Antonio, TX: Psychological Corporation.
4. Carroll, K. M., Easton, C. J., Nich, C., Hunkele, K. A., Neavins, T. M., Sinha, R., et al. (2006). The use of contingency management and motivationa/skills-building therapy to treat young adults with marijuana dependence. Journal of Consulting and Clinical Psychology, 74, 955-966. doi:10.1037/0022-006X.74.5.955
5. Charach, A., Volpe, T., Boydell, K. M., & Gearing, R. E. (2008). A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harvard Review of Psychiatry, 16, 126-135. doi:10.1080/10673220802069715
6. Chassin, L., Presson, C. C., Pitts, S. C., & Sherman, S. J. (2000). The natural history of cigarette smoking from adolescence to adulthood in a midwestern community sample: Multiple trajectories and their psychosocial correlates. Health Psychology, 19, 223-231. doi:10.1037/0278-6133.19.3.223
7. DiFranza, J. R., Savageau, J. A., Fletcher, K., Ockene, J. K., Rigotti, N. A., McNeill, A. D., et al. (2002). Measuring the loss of autonomy over nicotine use in adolescents: The DANDY (Development and Assessment of Nicotine Dependence in Youths) study. Archives of Pediatrics and Adolescent Medicine, 156, 397-403. Retrieved from http://archpedi.ama-assn.org/cgi/content/full/156/4/397
8. Eisenberg, M. J., Filion, K. B., Yavin, D., Bélisle, P., Mottillo, S., Joseph, L., et al. (2008). Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials. Canadian Medical Association Journal, 179, 135-144. doi:10.1503/cmaj.070256
9. Faessel, H., Ravva, P., & Williams, K. (2009). Pharmacokinetics, safety, and tolerability of varenicline in health adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics, 31, 177-189. doi:10.1016/j.clinthera.2009.01.003
10. Festinger, D. S., Marlowe, D. B., Dugosh, K. L., Croft, J. R., & Arabia, P. L. (2008). Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion. Drug and Alcohol Dependence, 96, 128-135. doi:10.1016/j.drugalcdep.2008.02.007
11. 2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 47-55. doi:10.1001/jama.296.1.47
12. Gray, K. M., Carpenter, M. J., Baker, N. L., Hartwell, K. J., Lewis, A. L., Hiott, D. W., et al. (2011). Bupropion SR and contingency management for adolescent smoking cessation. Journal of Substance Abuse Treatment, 40, 77-86. doi:10.1016/j.jsat.2010.08.010
13. Hanson, K., Allen, S., Jensen, S., & Hatsukami, D. (2003). Treatment of adolescent smokers with the nicotine patch. Nicotine and Tobacco Research, 5, 515-526. doi:10.1080/1462220031000118559
14. Harris, K. J., Golbeck, A. L., Cronk, N. J., Catley, D., Conway, K., & Williams, K. B. (2009). Timeline follow-back versus global self-reports of tobacco smoking: A comparison of findings with nondaily smokers. Psychology of Addictive Behaviors, 23, 368-372. doi:10.1037/a0015270
15. Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westerveld, M., Frost, S. J., & Pugh, K. R. (2005). Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biological Psychiatry, 57, 56-66. doi:10.1016/j.biopsych.2004.10.022
16. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2011). Monitoring the future national results on adolescent drug use: Overview of key findings, 2010. Ann Arbor, MI: Institute for Social Research, The University of Michigan. Retrieved from http://monitoringthefuture.org/pubs/monographs/mtf-overview2010.pdfon
17. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., et al. (2006). Efficacy of varenicline an a4b2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 56-63. doi:10.1001/jama.296.1.56
18. Kalachnik, J. E. (2001). Standardized monitoring for psychopharmacologic medication side effects. Manual for the Monitoring of Side Effects Scale (MOSES). Columbia, SC: University of South Carolina, School of Medicine, Department of Pediatrics, Center for Disability Resources, and the South Carolina Department of Disabilities and Special Needs.
19. Killen, J. D., Ammerman, S., Rohas, N., Varady, J., Haydel, F., & Robinson, T. N. (2001). Do adolescent smokers experience withdrawal effects when deprived of nicotine? Experimental and Clinical Psychopharmacology, 9, 176-182. doi:10.1037/1064-1297.9.2.176
20. Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., et al. (2004). Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. Journal of Consulting and Clinical Psychology, 72, 729-735. doi:10.1037/0022-006X.72.4.729
21. Ledgerwood, D. M., Alessi, S. M., Hanson, T., Godley, M. D., & Petry, N. M. (2008). Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics. Journal of Applied Behavioral Analysis, 41, 517-526. doi:10.1901/jaba.2008.41-517
22. McGuinness, T. M., & Worley, J. (2010). Promoting adherence to psychotropic medication for youth-part 1. Journal of Psychosocial Nursing and Mental Health Services, 48, 19-22. doi:10.3928/02793695-20100831-03
23. McLaughlin, T., Hogue, S. L., & Stang, P. E. (2007). Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression. American Journal of Therapeutics, 14, 221-225. doi:10.1097/01.mjt.0000208273.80496.3f
24. Meyer, R. E., Salzman, C., Youngstrom, E. A., Clayton, P. J., Goodwin, F. K., Mann, J. J., et al. (2010). Suicidality and risk of suicide-Definition, drug safety concerns, and a necessary target for drug development: A consensus statement. Journal of Clinical Psychiatry, 71, e1-e21. doi:10.4088/JCP.10cs06070blu
25. Moolchan, E. T., Robinson, M. L., Ernst, M., Cadet, J. L., Pickworth, W. B., Heishman, S. J., et al. (2005). Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics, 115, e407-e414. doi:10.1542/peds.2004-1894
26. Muramoto, M. L., Leischow, S. J., Sherrill, D., Matthews, E., & Strayer, L. J. (2007). Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Archives of Pediatrics and Adolescent Medicine, 161, 1068-1074. doi:10.1001/archpedi.161.11.1068
27. Nides, M., Oncken, C., Gonzales, D., Rennard, S., Watsky, E. J., Anziano, R., et al. (2006). Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Archives of Internal Medicine, 166, 1561-1568. doi:10.1001/archinte.166.15.1561
28. Posner, K., Brent, D., Lucas, C., Gould, M., Stanley, B., Brown, G., et al. (2007). Columbia-Suicide Severity Rating Scale (C-SSRS), New York, NY: The Research Foundation for Mental Hygiene, Inc.
29. Prokhorov, A. V., De Moor, C., Pallonen, U. E., Hudmon, K. S., Koehly, L., & Hu, S. (2000). Validation of the modified Fagerström tolerance questionnaire with salivary cotinine among adolescents. Addictive Behaviors, 25, 429-433. doi:10.1016/S0306-4603(98)00132-4
30. Prokhorov, A. V., Hudmon, K. S., de Moor, C. A., Kelder, S. H., Conroy, J. L., & Ordway, N. (2001). Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking. Nicotine and Tobacco Research, 3, 151-155. doi:10.1016/S0306-4603(98)00132-4
31. Rubinstein, M. L., Benowitz, N. L., Auerback, G. M., & Moscicki, A. B. (2008). A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics, 122, e595-e600. doi:10.1542/peds.2008-0501
32. Sheehan, D. V., Lecrubier, Y., Harnett-Sheehan, K., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, S22-S33.
33. Sheehan, D. V., Sheehan, K. H., Shytle, R. D., Janavs, J., Bannon, Y., Rogers, J. E., et al. (2010). Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). Journal of Clinical Psychiatry, 71, 313-326. doi:10.4088/JCP.09m05305whi
34. Sinha, R., Easton, C., Renee-Aubin, L., & Carroll, K. M. (2003). Engaging young probation-referred marijuana-abusing individuals in treatment: A pilot trial. American Journal on Addictions, 12, 314-323. doi:10.1111/j.1521-0391.2003.tb00546.x
35. Sobell, L. C., Sobell, M. B., Leo, G. I., & Cancilla, A. (1988). Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. British Journal of Addiction, 83, 393-402. doi:10.1111/j.1360-0443.1988.tb00485.x
36. Stang, P., Suppapanaya, N., Hogue, S. L., Park, D., & Rigney, U. (2007). Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population. American Journal of Therapeutics, 14, 241-246. doi:10.1097/MJT.0b013e31802b59e4
37. Stang, P., Young, S., & Hogue, S. (2007). Better patient persistence with once-daily bupropion compared with twice-daily bupropion. American Journal of Therapeutics, 14, 20-24. doi:10.1097/MJT.0b013e31802b5954
38. Stanton, W. R., McClelland, M., Elwood, C., Ferry, D., & Silva, P. A. (1996). Prevalence, reliability and bias of adolescents' reports of smoking and quitting. Addiction, 91, 1705-1714. doi:0965-2140/96/111705-10
39. Subramaniam, G., Harrell, P., Huntley, E., & Tracy, M. (2009). Beck Depression Inventory for depression screening in substance-abusing adolescents. Journal of Substance Abuse Treatment, 37, 25-31. doi:10.1016/j.jsat.2008.09.008
40. Substance Abuse and Mental Health Services Administration. (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Series H-34, DHHS Publication No. SMA 08-4343. Rockville, MD: Office of Applied Studies. Retrieved from http://oas.samhsa.gov/NSDUH/2k7NSDUH/2k7results.cfm#Ch4on
41. Sussman, S., Sun, P., & Dent, C. W. (2006). A meta-analysis of teen cigarette smoking cessation. Health Psychology, 25, 549-557. doi:10.1037/0278-6133.25.5.549
42. Zhu, S. H., Sun, J., Billings, S. C., Choi, W. S., & Malarcher, A. (1999). Predictors of smoking cessation in U.S. adolescents. American Journal of Preventive Medicine, 16, 202-207. doi:10.1016/S0749-3797(98)00157-3